METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 1,315.00
+2.00 (0.15%)
Sep 4, 2026, 3:30 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 29 billion as of September 4, 2026. Its market cap has decreased by -47.90% in one year.
Market Cap
29.00B
Enterprise Value
103.98B
Revenue
39.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,315.00
ChartMarket Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 29.00B, a decrease of -27.18%. That is a compound annual growth rate of -1.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 29.00B | -44.66% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 66.91T |
| Celltrion | 45.14T |
| ALTEOGEN | 20.09T |
| Samsung Epis Holdings | 8.84T |
| IMB Dx | 40.79B |
| HASS Corp. | 38.92B |
| LabGenomics | 37.12B |
| Tdspharm | 32.68B |